cTAPcTAPcTAPcTAP
  • WHAT WE DO
  • WHO WE ARE
  • HOW WE DO IT
  • NEWS
  • CONTACT
  • IS cTAP FOR YOU?
    • Biopharmaceutical Companies
    • Scientific Leaders & Researchers
    • Patient Organizations

2019 JSCN Abstract – Phase 1b/2 Study of RG6206

2019 JSCN Abstract – Phase 1b/2 Study of RG6206

A Phase 1b/2 study of RG6206 (BMS-986089) in boys with Duchenne muscular dystrophy: 72-week update

View the Full PDF

31
May 2019
Abstracts & Posters

Read the latest

  • cTAP Publishes Comprehensive Analysis of NSAA
  • Categorising trajectories and individual item changes of the NSAA in patients with DMD
  • 2019 EAN Abstract – Phase 1b/2 Study of RG6206
  • 2019 EU ISPOR Abstract – NSAA consistency analysis
  • 2019 EU ISPOR Abstract – Prognostic Model for Loss of Walking in DMD

COLLABORATIVE TRAJECTORY
ANALYSIS PROJECT

Cambridge Innovative Center
One Broadway, Cambridge, MA 02142

T: 617-555-5555
E: info@ctap-duchenne.org

© 2019 Collaborative Trajectory Analysis Project. All rights reserved.

  • WHAT WE DO
  • WHO WE ARE
  • HOW WE DO IT
  • NEWS
  • CONTACT
  • IS cTAP FOR YOU?
    • Biopharmaceutical Companies
    • Scientific Leaders & Researchers
    • Patient Organizations